July 31, 2025 9:15am
PRME closed Thursday up +$0.09 or +2.35% to $3.92 with an pre-open indication of -$0.44 or -11.22% to $3.48
38 M shares offered at $3.30 per share <see The Bottom Line>
Expecting to raise $125.4 M
TD Cowen and BMO Capital Markets are acting as joint book-running managers for the proposed offering.
The underwriters will not receive any discounts or commissions with respect to an aggregate of 1,818,181 shares of common stock sold to the Cystic Fibrosis Foundation.
PRME has also granted the underwriters a 30-day option to purchase up to an additional 5,700,000 shares of its common stock.
The Bottom Line: pieces of the stats puzzle – desperate straits
- Revenue: $3.85M
- Past Q Cash: $144.26 M
- Debt: $121.15 M
- 52-week High: 5.94 on 07/31/24
- 52-week Low: 1.11 on 05/22/25
- 52-week change: -31.73%
- Market Cap: 527.224M
- 50-day moving average: 2.6133
- 200-day moving average: 2.6688
- 10 Day Average Volume: 4.79M
- Float: 61.32 shares
- Shares short: 21.66 M
- Short % of Float (7/15/2025): 33.51%
- Shares Outstanding: 134.5 M
- % held by insiders: 23.65%
- % held by institutions:55.46%
- Beta: 2.32
- YTD % Change: -34.25%
